Company & Sponsor Intelligence
Centre for Addiction and Mental Health
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials10
Recruiting2
Completed8
Countries1
Therapeutic footprint
adhdalzheimersdepressioneating_disordersschizophrenia
Indexed studies
NCT03638284Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia
alzheimers · CanadaNA
alzheimers · CanadaNA
NCT02488499Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)
adhd · CanadaNA
adhd · CanadaNA
NCT04478838"Extended" (Alternate Day) Antipsychotic Dosing
schizophrenia · CanadaPHASE4
schizophrenia · CanadaPHASE4
NCT06373484Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents
adhd · CanadaNA
adhd · CanadaNA
NCT02800096Online Interventions for Gamblers With and Without Co-occurring Mental Health Concerns
depression · CanadaNA
depression · CanadaNA
NCT00493233Antipsychotic Polypharmacy in Schizophrenia
schizophrenia · CanadaNA
schizophrenia · CanadaNA
NCT03144986Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa
eating_disorders · CanadaNA
eating_disorders · CanadaNA
NCT00183560Preventing Depression Relapse With Mindfulness-Based Cognitive Therapy
depression · CanadaPHASE4
depression · CanadaPHASE4
NCT07495683Personalizing Psychosocial Intervention for Children With Disruptive Behaviour
adhd · NA
adhd · NA
NCT01847586Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease
alzheimers · CanadaNA
alzheimers · CanadaNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →